Expression of PTEN in the progression of cervical neoplasia and its relation to tumor behavior and angiogenesis in invasive squamous cell carcinoma

Journal of Surgical Oncology

Volumn 93, Issue 3, 2006, Pages 233-240

  Lee, Ji Shin ^a,d   Choi, Yoo Duk ^a   Lee, Jae Hyuk ^a   Nam, Jong Hee ^a   Choi, Chan ^a   Lee, Min Cheol ^a   Park, Chang Soo ^a   Kim, Hyung Seok ^b   Min, Kyung Whan ^c  

^a Chonnam National University Medical School   (South Korea)

^b Seonam University   (South Korea)

^c Deaconess Hospital Oklahoma City   (United States)

^d Chonnam National University Hwasun Hospital and Medical School   (South Korea)

Author keywords

Angiogenesis; Cervix neoplasm; PTEN

Indexed keywords

CD34 ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROVASCULATURE; MICROVESSEL DENSITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADULT; AGED; ANTIGENS, CD34; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; DISEASE PROGRESSION; EPITHELIUM; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PTEN PHOSPHOHYDROLASE; UTERINE CERVICAL NEOPLASMS;

EID: 33644906115     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20493     Document Type: Article

References (40)

1. Li J, Yen C, Liaw D, et al.: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-1947.
2. Liaw D, Marsh DJ, Li J, et al.: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64-67.
3. Lee JI, Soria JC, Hassan KA, et al.: Loss of PTEN expression as a prognostic marker for tongue cancer. Arch Otolaryngol Head Neck Surg 2001;27:1441-1445.
4. Tachibana M, Shibakita M, Ohno S, et al.: Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma. Cancer 2002;94:1955-1960.
5. Salvesen HB, Stefansson I, Kalvenes MB, et al.: Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma. Cancer 2002;94:2185-2191.
6. Lee JS, Kim HS, Kim YB, et al.: Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth. J Surg Oncol 2003;84:166-172.
7. Ellenson LH: Early molecular changes in endometrial cancer. Int J Gynecol Cancer 2005;15:399-400.
8. Kurose K, Zhou XP, Araki T, et al.: Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol 2001;158:2097-2106.
9. Tashiro H, Blazes MS, Wu R, et al.: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997;57:3935-3940.
10. Holway AH, Rieger-Christ KM, Miner WR, et al.: Somatic mutation of PTEN in vulvar cancer. Clin Cancer Res 2000;6:3228-3235.
11. Kurose K, Zhou XP, Araki T, et al.: Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas. Gene Chr Canc 2000;29:166-172.
12. Su TH, Chang JG, Perng LI, et al.: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer. Gynecol Oncol 2000;76:193-199.
13. Yaginuma Y, Yamashita T, Ishiya T, et al.: Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers. Mol Carcinog 2000;27:110-116.
14. Harima Y, Sawada S, Nagata K, et al.: Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy. Int J Oncol 2001;18:493-497.
15. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
16. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991;64:327-336.
17. Abulafia O, Triest WE, Sherer DM: Angiogenesis in malignancies of the female genital tract. Gynecol Oncol 1999;72:220-231.
18. Abulafia O, Sherer DM: Angiogenesis in the uterine cervix. Int J Gynecol Cancer 2000;10:349-357.
19. Lee JS, Kim HS, Jung JJ, et al.: Angiogenesis, cell proliferation and apoptosis in progression of cervical neoplasia. Analyt Quant Cytol Histol 2002;24:103-113.
20. Wen S, Stolarov J, Myers MP, et al.: PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci USA 2001;98:4622-4627.
21. Huang J, Kontos CD: PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem 2002;277:10760-10766.
22. Su JD, Mayo LD, Donner DB, et al.: PTEN and phosphatidylinositol 3′-kinase inhibitors upregulate p53 and block tumor-induced angiogenesis: Evidence for an effect on the tumor and endothelial compartment. Cancer Res 2003;63:3585-3592.
23. Giri D, Ittmann M: Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma. Hum Pathol 1999;30:419-424.
24. Richart RM: Cervical intraepithelial neoplasia. Pathol Annu 1973;8:301-328.
25. Shepherd JH: Cervical and vulva cancer: Changes in FIGO definition of staging. Br J Obstet Gynaecol 1996;103:405-406.
26. Reed JA, Manahan LJ, Park CS, et al.: Complete one-hour immunohistochemistry based on capillary action. Biotechniques 1992;13:434-443.
27. Bose S, Crane A, Hibshoosh H, et al.: Reduced expression of PTEN correlates with breast cancer progression. Hum Pathol 2002;33:405-409.
28. Walboomers JM, Jacobs MV, Manos MM, et al.: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
29. Wolf JK, Ramirez PT: The molecular biology of cervical cancer. Cancer Invest 2001;19:621-629.
30. Scheffner M, Munger K, Byrne JC, et al.: The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 1991;88:5523-5527.
31. Lee JS, Kim HS, Park JT, et al.: Expression of vascular endothelial growth factor in the progression of cervical neoplasia and its relation to angiogenesis and p53 status. Analyt Quant Cytol Histol 2003;25:303-311.
32. Klaes R, Friedrich T, Spitkovsky D, et al.: Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-284.
33. Krivak TC, McBroom JW, Seidman J, et al.: Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: A poor prognostic factor. Cancer Res 2001;61:4382-4385.
34. Perren A, Weng LP, Boag AH, et al.: Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol 1999;155:1253-1260.
35. Tsao H, Mihm MC, Jr., Sheehan C: PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma. J Am Acad Dermatol 2003;49:865-872.
36. Yang L, Kuang LG, Zheng HC, et al.: PTEN encoding product: A marker for tumorigenesis and progression of gastric carcinoma. World J Gastroenterol 2003;9:35-39.
37. Dellas A, Moch H, Schultheiss E, et al.: Angiogenesis in cervical neoplasia: Microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations. Gynecol Oncol 1997;67:27-33.
38. Tjalma W, Sonnemans H, Weyler J, et al.: Angiogenesis in cervical intraepithelial neoplasia and the risk of recurrence. Am J Obstet Gynecol 1999;181:554-559.
39. Avall-Lundqvist EH, Silfversward C, Aspenblad U, et al.: The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma. Eur J Cancer 1997;33:1799-1804.
40. Chung MJ, Jung SH, Lee BJ, et al.: Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer. Pathol Int 2004;54:10-15.